{"id":"W4416877007","doi":"10.1681/asn.202589fw4b2p","title":"ORIGIN 3: A Phase 3 Trial of Atacicept in IgAN","year":2025,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proteinuria; Placebo; Clinical endpoint; Nephropathy; Adverse effect; Randomized controlled trial; Urinary system; Interim analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001722405,0.001322995,0.002280526,0.0003553178,0.0004882898,0.001179895,0.001057514,0.001263627,0.006948048],"category_scores_gemma":[0.0009439511,0.0004120686,0.001795742,0.0003387964,0.0007218837,0.0009835041,0.000422505,0.003473618,0.001367923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008630839,"about_ca_system_score_gemma":0.001715138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009454664,"about_ca_topic_score_gemma":0.002676024,"domain_scores_codex":[0.9996409,0.0001501676,0.00002017635,0.0000592788,0.00004311469,0.00008627589],"domain_scores_gemma":[0.9993592,0.00009914004,0.0001278767,0.00006308844,0.00006240841,0.0002882963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8686091,0.02111354,0.002424926,0.001293713,0.001581676,0.0002527576,0.000220523,0.001239476,0.01610577,0.000433665,0.007515348,0.07920946],"study_design_scores_gemma":[0.8905435,0.1008549,0.003778105,0.00005043826,0.0003628027,0.0002168467,0.0000288058,0.0008208018,0.00119229,0.0002215737,0.00190705,0.00002286646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797563,0.007011604,0.001451303,0.001210649,0.0004781998,0.00316079,0.002740991,0.0004860222,0.003704211],"genre_scores_gemma":[0.9733557,0.004247453,0.004085773,0.002933842,0.0004135272,0.004874723,0.004581194,0.0001178878,0.005389874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006948048,"threshold_uncertainty_score":0.02324355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0220518277403114,"score_gpt":0.3382387921355389,"score_spread":0.3161869643952275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}